Ventyx biosciences to host virtual investor event on march 11, 2024

San diego, march 04, 2024 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that it will host a virtual investor event on monday, march 11, 2024 from 11:00 a.m. to 12:30 p.m. et.

VTYX Ratings Summary

VTYX Quant Ranking